FilingReader Intelligence
Jacobson Pharma reports revenue growth, increased profitability
July 3, 2025 at 10:50 AM UTC•By FilingReader AI
Jacobson Pharma Corporation Limited (HKEX:2633) announced its 2024/2025 annual results, demonstrating growth and increased profitability. Revenue reached HKD 1,576.9 million, a 7.4% increase from the previous year. Net profit rose significantly by 43.1% to HKD 300.8 million. This profit surge was supported by improved operating efficiency and specialty medicine contributions.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
HKEX:2633•Hong Kong Exchange
News Alerts
Get instant email alerts when Jacobson Pharma Corp publishes news
Free account required • Unsubscribe anytime